Case Control Psychological Autopsy of Suicide

October 16, 2021 updated by: Tamkeen Saleem

Psychological Autopsy: An Investigation to Explore Antecedents, Sequelae and Causes of Case Control Suicide Equivocal Behavior

Suicide is a leading cause of death worldwide, and identifying risk factors has been considered as the key initiative of suicide prevention. Considering that, the study aimed to explore the factors leading towards suicide in Pakistan through Case-Control Psychological Autopsy of Suicide. Also, the study aimed to Translate, Adapt and Validate American Association of Suicidology (AAS) Semi-Structured Interview for Psychological Autopsy (Generic Version, 2018).

Study Overview

Status

Enrolling by invitation

Study Type

Observational

Enrollment (Anticipated)

50

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Capital
      • Islamabad, Capital, Pakistan, 44000
        • International Islamic University, Islamabad Pakistan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

10 years to 35 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Cases are those individuals who died by suicide and the controls include individuals who survive after attempting suicide.

Description

Inclusion Criteria:

  • The age of the deceased by suicide and living controls will range from 10 to 35 years.
  • The key informants will be of 18 years of age and above without any learning
  • disability.
  • The key informants will be a close family member or immediate friend.
  • Only suicides took place in 2019 to September 2021.

Exclusion Criteria:

  • If contact was deemed to pose a risk to the safety of the researcher (likely intoxication; history of or potential for violence).
  • Informants who are not willing to give written informed consent will be excluded from the study.
  • Informants who are taking any psychological help in the past and present will be excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Case
Case (Fatal Suicide)
Control
Control (Non-Fatal Suicidal Behavior)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Semi-structured Interview for Psychological Autopsy
Time Frame: Upto 6 months
American Association of Suicidology Semi-Structured Interview for Psychological Autopsy
Upto 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Dr Tamkeen Saleem, PhD, International Islamic University, Islamabad, Pakistan
  • Study Chair: Dr Michelle O'Reilly, PhD, University of Leicester and Leicestershire Partnership NHS Trust
  • Study Chair: Dr Domenico Giacco, PhD, Warwick Medical School, University of Warwick

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 14, 2021

Primary Completion (Anticipated)

February 25, 2022

Study Completion (Anticipated)

March 30, 2022

Study Registration Dates

First Submitted

September 25, 2021

First Submitted That Met QC Criteria

October 16, 2021

First Posted (Actual)

October 28, 2021

Study Record Updates

Last Update Posted (Actual)

October 28, 2021

Last Update Submitted That Met QC Criteria

October 16, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • AAS-ATV-PAS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicide

3
Subscribe